• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (15)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Nutritional and Metabolic Disorders  • Lipids and Lipid Disorders  • Nutritional and Metabolic Disorders, Other  • Cardiovascular System  • Cardiovascular Disease/ Myocardial Infarction  • Drug Therapy  • Drug Therapy, Other  • Endocrine Diseases  • Diabetes Mellitus  • Hypertension  • Alert me on articles by topic  Social Bookmarking   What's this?

Devin M. Mann, MD, MS; Mark Woodward, PhD; Fen Ye, MS; Marie Krousel-Wood, MD; Paul Muntner, PhD

Arch Intern Med. 2009;169(18):1718-1720.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Successful reduction of cardiovascular disease (CVD) risk among people with diabetes mellitus is increasingly reliant on combination pharmacotherapy targeting its major risk factors, especially hypertension and high cholesterol level.¹ The impact of tight hyperglycemia control on CVD and mortality risk is currently unclear, but its control is a major part of comprehensive diabetes care and is also increasingly attained through combination therapy.^2-4 We sought to examine the competing treatment priorities for US adults with diabetes by analyzing the use of antidiabetes, antihypertensive, and statin medications over time from the population-based National Health and Nutrition Examination Survey (NHANES) between 1999 and 2006.

Methods

NHANES 1999-2000, 2001-2002, 2003-2004, and 2005-2006 are serial cross-sectional surveys including nationally representative samples of the noninstitutionalized civilian US population identified through a stratified, multistage probability sampling design.⁵ The present analysis was . . . [Full Text of this Article]

Results

Comment

AUTHOR INFORMATION


CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Evaluation of Guideline Recommendations on Oral Medications for Type 2 Diabetes Mellitus: A Systematic Review
Bennett et al.
ANN INTERN MED 2012;156:27-36.
ABSTRACT | FULL TEXT  

A web-based diabetes intervention for physician: a cluster-randomized effectiveness trial
Estrada et al.
Int J Qual Health Care 2011;23:682-689.
ABSTRACT | FULL TEXT  

Are Individuals With Diabetes Seeing Better?: A Long-Term Epidemiological Perspective
Klein and Klein
Diabetes 2010;59:1853-1860.
FULL TEXT  

Nutritional intervention in patients with type 2 diabetes who are hyperglycaemic despite optimised drug treatment--Lifestyle Over and Above Drugs in Diabetes (LOADD) study: randomised controlled trial
Coppell et al.
BMJ 2010;341:c3337-c3337.
ABSTRACT | FULL TEXT